MobiHealth News November 20, 2020
Authors from GIMBHI and Columbia Psychiatry Mind Ventures write about the future of digital therapeutics.
Considered one of the most innovative areas within digital health, the prescription digital therapeutics (PDT) ecosystem has experienced an accelerated period of progress over the past two years. A prescription digital therapeutic is a prescription-only software that delivers evidence-based therapeutic intervention(s) to prevent, manage or treat a medical disorder or disease.
While considerable progress has been made, the question remains whether digital therapeutics can successfully and sustainably integrate into the U.S. healthcare system. Regulatory challenges and payer adoption are challenges that have dominated the conversation so far in the PDT world, but clinical validation, FDA approvals and reimbursement coverage aren’t enough. Physician adoption is...